Bright Minds Biosciences (DRUG) Intangibles (2020 - 2022)

Bright Minds Biosciences' Intangibles history runs 3 years deep, the most recent figure standing at $1568.7 for Q2 2022.

• Quarterly Intangibles fell 3.59% year-over-year to $1568.7 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $1568.7 (down 3.59% YoY) and the FY2021 annual result came in at $1588.8, up 5.86% from the prior year.
• Intangibles was $1568.7 for Q2 2022 at Bright Minds Biosciences, down from $1579.0 in the prior quarter.
• Across five years, Intangibles topped out at $1627.1 in Q2 2021 and bottomed at $1500.8 in Q3 2020.
• A 3-year average of $1575.2 and a median of $1582.8 in 2021 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2021 — Intangibles gained 5.86% — and 2022, when it dropped 3.59%.
• Bright Minds Biosciences' Intangibles stood at $1500.8 in 2020, then grew by 5.72% to $1586.7 in 2021, then slipped by 1.13% to $1568.7 in 2022.
• Business Quant data shows DRUG's Intangibles at $1568.7 in Q2 2022, $1579.0 in Q1 2022, and $1586.7 in Q4 2021.